Vissum Corporation, Alicante, Spain.
Ophthalmology. 2012 Mar;119(3):555-63. doi: 10.1016/j.ophtha.2011.08.036. Epub 2012 Jan 3.
To compare the visual acuity outcomes and ocular optical performance of eyes implanted with a multifocal refractive intraocular lens (IOL) with an inferior segmental near add or a diffractive multifocal IOL.
Prospective, comparative, nonrandomized, consecutive case series.
Eighty-three consecutive eyes of 45 patients (age range, 36-82 years) with cataract were divided into 2 groups: group A, 45 eyes implanted with Lentis Mplus LS-312 (Oculentis GmbH, Berlin, Germany); group B, 38 eyes implanted with diffractive IOL Acri.Lisa 366D (Zeiss, Oberkochen, Germany).
All patients underwent phacoemulsification followed by IOL implantation in the capsular bag. Distance corrected, intermediate, and near with the distance correction visual acuity outcomes and contrast sensitivity, intraocular aberrations, and defocus curve were evaluated postoperatively during a 3-month follow-up.
Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected near visual acuity (UNVA), corrected distance near and intermediate visual acuity (CDNVA), contrast sensitivity, intraocular aberrations, and defocus curve.
A significant improvement in UDVA, CDVA, and UNVA was observed in both groups after surgery (P ≤ 0.04). Significantly better values of UNVA (P<0.01) and CDNVA (P<0.04) were found in group B. In the defocus curve, significantly better visual acuities were present in eyes in group A for intermediate vision levels of defocus (P ≤ 0.04). Significantly higher amounts of postoperative intraocular primary coma and spherical aberrations were found in group A (P<0.01). In addition, significantly better values were observed in photopic contrast sensitivity for high spatial frequencies in group A (P ≤ 0.04).
The Lentis Mplus LS-312 and Acri.Lisa 366D IOLs are able to successfully restore visual function after cataract surgery. The Lentis Mplus LS-312 provided better intermediate vision and contrast sensitivity outcomes than the Acri.Lisa 366D. However, the Acri.Lisa design provided better distance and near visual outcomes and intraocular optical performance parameters.
比较植入多焦点折射型人工晶状体(IOL)与具有下节近附加或衍射多焦点 IOL 的眼的视力结果和眼部光学性能。
前瞻性、对比、非随机、连续病例系列。
45 名患者(年龄 36-82 岁)的 83 只连续眼被分为 2 组:A 组,45 只眼植入 Lentis Mplus LS-312(Oculentis GmbH,柏林,德国);B 组,38 只眼植入衍射 IOL Acri.Lisa 366D(蔡司,Oberkochen,德国)。
所有患者均行白内障超声乳化术,随后在囊袋内植入 IOL。术后 3 个月随访期间,评估距离矫正、中间、近距和距离矫正视力结果以及对比敏感度、眼内像差和离焦曲线。
未矫正远视力(UDVA)、矫正远视力(CDVA)、未矫正近视力(UNVA)、矫正远中近视力(CDNVA)、对比敏感度、眼内像差和离焦曲线。
两组术后 UDVA、CDVA 和 UNVA 均显著提高(P≤0.04)。B 组 UNVA(P<0.01)和 CDNVA(P<0.04)的改善值显著更好。在离焦曲线中,A 组中间距离离焦的视力明显更好(P≤0.04)。A 组术后眼内初级彗差和球差明显增加(P<0.01)。此外,A 组在高空间频率的明视对比敏感度方面,观察到明显更好的值(P≤0.04)。
Lentis Mplus LS-312 和 Acri.Lisa 366D IOL 均可成功地在白内障手术后恢复视力功能。Lentis Mplus LS-312 提供了更好的中距离视力和对比敏感度结果,优于 Acri.Lisa 366D。然而,Acri.Lisa 设计提供了更好的距离和近视力结果以及眼内光学性能参数。